- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Minimal Residual Disease in Acute Lymphoblastic Leukemia ; volume:42 ; number:01 ; year:2021 ; pages:071-076
Indian journal of medical & paediatric oncology ; 42, Heft 01 (2021), 071-076
- Contributor
-
Patil, Pratik P.
Jafa, Esha
Aggarwal, Mayank
- DOI
-
10.1055/s-0041-1729730
- URN
-
urn:nbn:de:101:1-2021081213371734029613
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Patil, Pratik P.
- Jafa, Esha
- Aggarwal, Mayank
Other Objects (12)
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
Detection of minimal residual disease in childhood acute lymphoblastic leukemia by digital droplet PCR
Advanced minimal residual disease monitoring for acute lymphoblastic leukemia with multiplex mediator probe PCR
Acute lymphoblastic leukemia
Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey
Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia
Clinicians’ Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study
Effect of Dose and Schedule of L-Asparaginase Administration on Early Minimal Residual Disease in Acute Lymphoblastic Leukemia
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
Detection of minimal residual disease in childhood acute lymphoblastic leukemia by digital droplet PCR
Advanced minimal residual disease monitoring for acute lymphoblastic leukemia with multiplex mediator probe PCR
Acute lymphoblastic leukemia
Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey
Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia
Clinicians’ Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study
Effect of Dose and Schedule of L-Asparaginase Administration on Early Minimal Residual Disease in Acute Lymphoblastic Leukemia
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
Detection of minimal residual disease in childhood acute lymphoblastic leukemia by digital droplet PCR
Advanced minimal residual disease monitoring for acute lymphoblastic leukemia with multiplex mediator probe PCR
Acute lymphoblastic leukemia
Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey
Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia
Clinicians’ Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study
Effect of Dose and Schedule of L-Asparaginase Administration on Early Minimal Residual Disease in Acute Lymphoblastic Leukemia
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia